
Sign up to save your podcasts
Or


Vidcast: https://youtu.be/tG60v5wIJk0
To better understand this rapidly spreading disease, French infectious disease researchers reviewed the records of 264 PCR-confirmed monkeypox patients. 99% were men with a median age of 35 years, 29% were HIV-positive, 71% were taking PrEP, and 11% were smallpox-vaccinated.
In 53%, there were no symptoms such as fever or lymph node swelling prior to the appearance of skin lesions. Complications occurred in 36%. All but one patient developed a bacterial superinfection requiring antibacterials. Hospitalization was required in 6% for cellulitis, severe gastrointestinal infection, and other miscellaneous issues. No mention was made in the study of TPOXX use.
https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(22)00428-1/fulltext?dgcid=raven_jbs_aip_email
#monkeypox #complications #hospitalization
By Howard G. Smith MD, AM
Vidcast: https://youtu.be/tG60v5wIJk0
To better understand this rapidly spreading disease, French infectious disease researchers reviewed the records of 264 PCR-confirmed monkeypox patients. 99% were men with a median age of 35 years, 29% were HIV-positive, 71% were taking PrEP, and 11% were smallpox-vaccinated.
In 53%, there were no symptoms such as fever or lymph node swelling prior to the appearance of skin lesions. Complications occurred in 36%. All but one patient developed a bacterial superinfection requiring antibacterials. Hospitalization was required in 6% for cellulitis, severe gastrointestinal infection, and other miscellaneous issues. No mention was made in the study of TPOXX use.
https://www.clinicalmicrobiologyandinfection.com/article/S1198-743X(22)00428-1/fulltext?dgcid=raven_jbs_aip_email
#monkeypox #complications #hospitalization